Examkin

Soru

Zorluk: ZorGenetic and Molecular Mechanisms

During a routine health maintenance visit, a 42-year-old male accountant reports a gradual but significant decline in his exercise tolerance over the past two years. Previously an avid runner, he now experiences dyspnea after walking up a single flight of stairs. He is a lifelong non-smoker. His family history is notable for a father who died from cryptogenic liver cirrhosis at age 52. On physical examination, the patient has an increased anteroposterior chest diameter and globally diminished breath sounds. Spirometry reveals a forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC\text{FEV}_1/\text{FVC}) of 62%62\%, and carbon monoxide diffusing capacity (DLCO) is reduced to 45%45\% of the predicted value. Serum laboratory analysis demonstrates an aspartate aminotransferase level of 8585 U/L (reference range: 8−408-40 U/L) and an alanine aminotransferase level of 9292 U/L (reference range: 7−567-56 U/L). A chest radiograph displays significant hyperlucency at the lung bases. Which of the following best describes the molecular mechanism responsible for this patient's hepatic findings?

  1. Accumulation of a polymerized, misfolded glycoprotein within the rough endoplasmic reticulumCevap
  2. B
    Uninhibited serine protease activity leading to structural tissue degradation
  3. C
    Accelerated proteasomal degradation of a structurally abnormal transmembrane ion channel
  4. D
    Downregulation of hepcidin synthesis leading to unregulated intestinal iron absorption
  5. E
    Inherited polymorphism in a cytochrome P450 enzyme leading to impaired xenobiotic clearance

Cevap

The correct answer identifies the accumulation of a polymerized, misfolded glycoprotein within the rough endoplasmic reticulum.
The correct answer identifies the distinct hepatic pathogenesis of alpha-1 antitrypsin (AAT) deficiency. The patient's clinical presentation of early-onset, lower-lobe predominant panacinar emphysema in a non-smoker, combined with unexplained liver disease, is classic for the PiZZ genotype of AAT deficiency. The PiZZ missense mutation causes the AAT glycoprotein to misfold. Because it is improperly folded, it cannot be secreted from the hepatocyte into the bloodstream. Instead, the mutant AAT molecules polymerize and accumulate within the rough endoplasmic reticulum (ER). This accumulation causes severe ER stress and hepatocellular apoptosis, eventually leading to liver cirrhosis.

Adım Adım Çözüm

1
Synthesize the clinical and diagnostic findings.
The patient presents with early-onset, lower-lobe predominant panacinar emphysema (obstructive pattern, low DLCO, hyperlucency) and evidence of liver disease (elevated transaminases, family history of cirrhosis) in a non-smoker. This constellation is highly specific for alpha-1 antitrypsin (AAT) deficiency.
Accurately identifying the overarching syndrome is necessary to evaluate its underlying pathophysiology.
2
Differentiate the molecular mechanisms responsible for the pulmonary versus hepatic manifestations of the disease.
While the lung disease is caused by a loss-of-function (absence of AAT allows uninhibited neutrophil elastase to destroy alveolar walls), the liver disease is caused by a toxic gain-of-function. The PiZZ mutation causes the AAT protein to misfold and polymerize, trapping it in the rough endoplasmic reticulum of hepatocytes.
The question specifically asks for the mechanism of the hepatic findings, requiring the distinction between the two parallel disease processes.

Anahtar Kavram

Alpha-1 antitrypsin deficiency causes liver disease via a toxic gain-of-function mechanism, where misfolded AAT polymers accumulate in the rough endoplasmic reticulum of hepatocytes, causing ER stress and eventual cirrhosis.
Bu soruyu puanla

Konular

Genetic and Molecular Mechanisms

Bu konudan daha fazla soru